3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
84
Kidney Neoplasms
22
Prostatic Neoplasms
14
Neoplasm Metastasis
10
Neoplasms
9
Urinary Bladder Neoplasms
8
Carcinoma, Hepatocellular
5
Liver Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Carcinoma
3
Urethral Neoplasms
2
Sarcoma
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioblastoma
2
Financial Stress
2
Wilms Tumor
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Germ Cell and Embryonal
1
Interventions
Cyclophosphamide
4
Etoposide
3
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Sirolimus
2
Paclitaxel
2
Mesna
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Cisplatin
2
Carboplatin
2
Busulfan
2
Brentuximab Vedotin
2
tremelimumab
1
ripretinib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
pazopanib
1
guadecitabine
1
fosaprepitant
1
fludarabine phosphate
1
durvalumab
1
bintrafusp alfa protein, human
1
avelumab
1
Vorinostat
1
Ursodeoxycholic Acid
1
Topotecan
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Sorafenib
×
Genitourinary
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled